Genetic localization to chromosome 1p32 of the third locus for familial hypercholesterolemia in a Utah kindred

Steven Hunt, Paul N. Hopkins, Katrina Bulka, Michael T. McDermott, Thomas L. Thorne, Bryan B. Wardell, Benjamin R. Bowen, Dennis G. Ballinger, Mark H. Skolnick, Mark E. Samuels

Research output: Contribution to journalArticle

82 Citations (Scopus)

Abstract

Clinical familial hypercholesterolemia has been shown to result from mutations in 2 genes, the low density lipoprotein (LDL) receptor on chromosome 19 and apolipoprotein B on chromosome 2. However, we have recently described a Utah pedigree in which linkage to both genes was clearly excluded. A multipoint linkage analysis of 583 markers genotyped on 31 (18 affected) members of this pedigree was undertaken to localize a genetic region that may harbor a third gene that could result in clinical familial hypercholesterolemia. A multipoint log of the odds score of 6.8 was obtained for markers on 1p32. Haplotype carders and affected status are completely concordant (18/18 persons). The phenotype is also expressed in young children (ages 4 and 9). Specific recombinant individuals in the pedigree restrict the region of linkage to an ≃ 17 cM interval between polymorphic markers D1S2130 and D1S1596. This region appears to overlap the region found linked to severe hypercholesterolemia in French and Spanish families. The identification of the gene in this region may provide important pathophysiological insights into new mechanisms that may lead to highly elevated LDL cholesterol and other associated dyslipidemic phenotypes.

Original languageEnglish
Pages (from-to)1089-1093
Number of pages5
JournalArteriosclerosis, Thrombosis, and Vascular Biology
Volume20
Issue number4
Publication statusPublished - Apr 2000
Externally publishedYes

Fingerprint

Hyperlipoproteinemia Type II
Pedigree
Chromosomes
Genes
Chromosomes, Human, 4-5
Phenotype
Chromosomes, Human, Pair 19
Chromosomes, Human, Pair 2
LDL Receptors
Apolipoproteins B
Hypercholesterolemia
LDL Cholesterol
Haplotypes
Mutation

Keywords

  • Familial hypercholesterolemia
  • Genetics
  • LDL cholesterol
  • Linkage analysis

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Cite this

Hunt, S., Hopkins, P. N., Bulka, K., McDermott, M. T., Thorne, T. L., Wardell, B. B., ... Samuels, M. E. (2000). Genetic localization to chromosome 1p32 of the third locus for familial hypercholesterolemia in a Utah kindred. Arteriosclerosis, Thrombosis, and Vascular Biology, 20(4), 1089-1093.

Genetic localization to chromosome 1p32 of the third locus for familial hypercholesterolemia in a Utah kindred. / Hunt, Steven; Hopkins, Paul N.; Bulka, Katrina; McDermott, Michael T.; Thorne, Thomas L.; Wardell, Bryan B.; Bowen, Benjamin R.; Ballinger, Dennis G.; Skolnick, Mark H.; Samuels, Mark E.

In: Arteriosclerosis, Thrombosis, and Vascular Biology, Vol. 20, No. 4, 04.2000, p. 1089-1093.

Research output: Contribution to journalArticle

Hunt, S, Hopkins, PN, Bulka, K, McDermott, MT, Thorne, TL, Wardell, BB, Bowen, BR, Ballinger, DG, Skolnick, MH & Samuels, ME 2000, 'Genetic localization to chromosome 1p32 of the third locus for familial hypercholesterolemia in a Utah kindred', Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 20, no. 4, pp. 1089-1093.
Hunt, Steven ; Hopkins, Paul N. ; Bulka, Katrina ; McDermott, Michael T. ; Thorne, Thomas L. ; Wardell, Bryan B. ; Bowen, Benjamin R. ; Ballinger, Dennis G. ; Skolnick, Mark H. ; Samuels, Mark E. / Genetic localization to chromosome 1p32 of the third locus for familial hypercholesterolemia in a Utah kindred. In: Arteriosclerosis, Thrombosis, and Vascular Biology. 2000 ; Vol. 20, No. 4. pp. 1089-1093.
@article{a01922feca5c416da74374bd9f5842d3,
title = "Genetic localization to chromosome 1p32 of the third locus for familial hypercholesterolemia in a Utah kindred",
abstract = "Clinical familial hypercholesterolemia has been shown to result from mutations in 2 genes, the low density lipoprotein (LDL) receptor on chromosome 19 and apolipoprotein B on chromosome 2. However, we have recently described a Utah pedigree in which linkage to both genes was clearly excluded. A multipoint linkage analysis of 583 markers genotyped on 31 (18 affected) members of this pedigree was undertaken to localize a genetic region that may harbor a third gene that could result in clinical familial hypercholesterolemia. A multipoint log of the odds score of 6.8 was obtained for markers on 1p32. Haplotype carders and affected status are completely concordant (18/18 persons). The phenotype is also expressed in young children (ages 4 and 9). Specific recombinant individuals in the pedigree restrict the region of linkage to an ≃ 17 cM interval between polymorphic markers D1S2130 and D1S1596. This region appears to overlap the region found linked to severe hypercholesterolemia in French and Spanish families. The identification of the gene in this region may provide important pathophysiological insights into new mechanisms that may lead to highly elevated LDL cholesterol and other associated dyslipidemic phenotypes.",
keywords = "Familial hypercholesterolemia, Genetics, LDL cholesterol, Linkage analysis",
author = "Steven Hunt and Hopkins, {Paul N.} and Katrina Bulka and McDermott, {Michael T.} and Thorne, {Thomas L.} and Wardell, {Bryan B.} and Bowen, {Benjamin R.} and Ballinger, {Dennis G.} and Skolnick, {Mark H.} and Samuels, {Mark E.}",
year = "2000",
month = "4",
language = "English",
volume = "20",
pages = "1089--1093",
journal = "Arteriosclerosis, Thrombosis, and Vascular Biology",
issn = "1079-5642",
publisher = "Lippincott Williams and Wilkins",
number = "4",

}

TY - JOUR

T1 - Genetic localization to chromosome 1p32 of the third locus for familial hypercholesterolemia in a Utah kindred

AU - Hunt, Steven

AU - Hopkins, Paul N.

AU - Bulka, Katrina

AU - McDermott, Michael T.

AU - Thorne, Thomas L.

AU - Wardell, Bryan B.

AU - Bowen, Benjamin R.

AU - Ballinger, Dennis G.

AU - Skolnick, Mark H.

AU - Samuels, Mark E.

PY - 2000/4

Y1 - 2000/4

N2 - Clinical familial hypercholesterolemia has been shown to result from mutations in 2 genes, the low density lipoprotein (LDL) receptor on chromosome 19 and apolipoprotein B on chromosome 2. However, we have recently described a Utah pedigree in which linkage to both genes was clearly excluded. A multipoint linkage analysis of 583 markers genotyped on 31 (18 affected) members of this pedigree was undertaken to localize a genetic region that may harbor a third gene that could result in clinical familial hypercholesterolemia. A multipoint log of the odds score of 6.8 was obtained for markers on 1p32. Haplotype carders and affected status are completely concordant (18/18 persons). The phenotype is also expressed in young children (ages 4 and 9). Specific recombinant individuals in the pedigree restrict the region of linkage to an ≃ 17 cM interval between polymorphic markers D1S2130 and D1S1596. This region appears to overlap the region found linked to severe hypercholesterolemia in French and Spanish families. The identification of the gene in this region may provide important pathophysiological insights into new mechanisms that may lead to highly elevated LDL cholesterol and other associated dyslipidemic phenotypes.

AB - Clinical familial hypercholesterolemia has been shown to result from mutations in 2 genes, the low density lipoprotein (LDL) receptor on chromosome 19 and apolipoprotein B on chromosome 2. However, we have recently described a Utah pedigree in which linkage to both genes was clearly excluded. A multipoint linkage analysis of 583 markers genotyped on 31 (18 affected) members of this pedigree was undertaken to localize a genetic region that may harbor a third gene that could result in clinical familial hypercholesterolemia. A multipoint log of the odds score of 6.8 was obtained for markers on 1p32. Haplotype carders and affected status are completely concordant (18/18 persons). The phenotype is also expressed in young children (ages 4 and 9). Specific recombinant individuals in the pedigree restrict the region of linkage to an ≃ 17 cM interval between polymorphic markers D1S2130 and D1S1596. This region appears to overlap the region found linked to severe hypercholesterolemia in French and Spanish families. The identification of the gene in this region may provide important pathophysiological insights into new mechanisms that may lead to highly elevated LDL cholesterol and other associated dyslipidemic phenotypes.

KW - Familial hypercholesterolemia

KW - Genetics

KW - LDL cholesterol

KW - Linkage analysis

UR - http://www.scopus.com/inward/record.url?scp=0034127788&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0034127788&partnerID=8YFLogxK

M3 - Article

VL - 20

SP - 1089

EP - 1093

JO - Arteriosclerosis, Thrombosis, and Vascular Biology

JF - Arteriosclerosis, Thrombosis, and Vascular Biology

SN - 1079-5642

IS - 4

ER -